Currently out of the existing stock ratings of Richard Vosser, 40 are a BUY (51.28%), 29 are a HOLD (37.18%), 9 are a SELL (11.54%).
Analyst Richard Vosser, currently employed at JPMORGAN, has had 48.48% of price targets met with an average potential upside of 21.66%, reached in 281 days on average. Previously, Richard Vosser worked at MORGAN STANLEY.
Richard Vosser has documented 134 price targets and ratings displayed on 11 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 24-Feb-2026.
Analyst best performing recommendations are on RH (RH).
The best stock recommendation documented was for RH (RH) on 1/3/2023. The price target of $294.29 was fulfilled within 6 days with a profit of $41.01 (16.19%), with a performance score of 26.99.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 14-May-2025
$40
$-1.63 (-3.92%)
$47
1 months 3 days ago
(12-Oct-2026)
13/26 (50%)
$1.36 (3.52%)
29
Hold Since 11-Sep-2026
$40
$-1.63 (-3.92%)
$40
2 months 4 days ago
(11-Sep-2026)
4/4 (100%)
$-3.07 (-7.13%)
32
Buy Since 20-Nov-2025
$62
4 months 29 days ago
(17-Jun-2026)
1/2 (50%)
$15.28 (32.71%)
210
Hold Since 03-Jun-2026
$47
$5.37 (12.90%)
$41
5 months 12 days ago
(03-Jun-2026)
3/6 (50%)
$5.53 (13.33%)
41
Buy Since 07-Jun-2022
8 months 22 days ago
(24-Feb-2026)
10/10 (100%)
$32.06 (35.10%)
255
What Year was the first public recommendation made by Richard Vosser?
